| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |